Aug 5 |
Rigel Pharmaceuticals Q2 2024 Earnings Preview
|
Jul 31 |
Collegium Pharmaceutical (COLL) Soars 10.6%: Is Further Upside Left in the Stock?
|
Jul 30 |
Rigel Pharmaceuticals (RIGL) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
|
Jul 30 |
Rigel Announces Conference Call and Webcast to Report Second Quarter 2024 Financial Results and Business Update
|
Jul 24 |
Rigel Pharmaceuticals: Undervalued FDA-Approved Products With Promising Cash Flow Potential
|
Jul 17 |
Rigel Pharmaceuticals, Inc.'s (NASDAQ:RIGL) Intrinsic Value Is Potentially 87% Above Its Share Price
|
Jun 25 |
Rigel announces reverse stock split
|
Jun 25 |
Rigel Announces Reverse Stock Split
|
Jun 24 |
Rigel Pharmaceuticals Completes Transfer of GAVRETO® (pralsetinib) New Drug Application
|
Jun 14 |
Rigel Announces Five Presentations at the EHA2024 Hybrid Congress
|